SHANNON GRAY: Open Payments
NPI 1770186538 · FLORENCE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$477 in 26 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $374 · 2025 $477
Food & beverage: $477
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $121 |
| AstraZeneca Pharmaceuticals LP | 5 | $85 |
| Astellas Pharma US Inc | 3 | $67 |
| ABBVIE INC. | 3 | $47 |
| Novo Nordisk Inc | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Optinose US, Inc. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: MOUNJARO, Veozah, AIRSUPRA, UBRELVY, Wegovy, VOQUEZNA, KEVEYIS, CAPLYTA.
Industry payments across AZ — which companies pay providers there.
